174 related articles for article (PubMed ID: 6328894)
1. Non-B hepatocellular carcinoma: influence of age, sex, alcohol, family clustering, blood transfusion and chronic liver disease.
Yamada G; Mizuno M; Kinoyama S; Nishihara T; Okushin H; Hyodo I; Sakamoto Y; Nagashima H
Acta Med Okayama; 1984 Apr; 38(2):181-91. PubMed ID: 6328894
[TBL] [Abstract][Full Text] [Related]
2. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Aikawa T; Tanaka N; Osuga T
J Gastroenterol; 1996 Aug; 31(4):552-8. PubMed ID: 8844477
[TBL] [Abstract][Full Text] [Related]
5. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
6. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease.
Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H
Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699
[TBL] [Abstract][Full Text] [Related]
7. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol.
Villa E; Baldini GM; Pasquinelli C; Melegari M; Cariani E; Di Chirico G; Manenti F
Cancer; 1988 Aug; 62(3):611-5. PubMed ID: 2839286
[TBL] [Abstract][Full Text] [Related]
10. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
11. [Liver cirrhosis in Asia and Africa].
Iwamura K
Z Gastroenterol; 1983 Nov; 21(11):637-43. PubMed ID: 6318465
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.
Kwon OS; Jung YK; Bae KS; Kim JH; Kim SG; Kim YS; Lee JI; Lee JW; Kim YS
Alcohol; 2012 Sep; 46(6):537-41. PubMed ID: 22572059
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C infection and liver cell carcinoma].
Maier KP
Schweiz Rundsch Med Prax; 1992 Aug; 81(34):978-9. PubMed ID: 1382306
[TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.
Sakamoto M; Hirohashi S; Tsuda H; Ino Y; Shimosato Y; Yamasaki S; Makuuchi M; Hasegawa H; Terada M; Hosoda Y
Cancer Res; 1988 Dec; 48(24 Pt 1):7294-7. PubMed ID: 2847867
[TBL] [Abstract][Full Text] [Related]
17. [Current status and therapeutic strategy for hepatocellular carcinoma].
Unoura M; Adachi K; Kawai H; Inagaki Y; Kaneko S; Kobayashi K
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):608-14. PubMed ID: 2157367
[TBL] [Abstract][Full Text] [Related]
18. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B antigens and antibodies in serum from 41 cases of primary carcinoma of the liver. A study from Thailand.
Nørredam K; Chainuvati T; Aldershvile J; Nielsen JO; Viranuvatti V
Scand J Gastroenterol; 1986 May; 21(4):428-32. PubMed ID: 3014639
[TBL] [Abstract][Full Text] [Related]
20. Presence of HBsAg and anti-HBs in patients with primary liver cancer or hepatic metastases.
Nastac E; Stoian M; Iosipenco M; Iordache C
Virologie; 1985; 36(3):181-6. PubMed ID: 3000067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
